{"disease":{"id":"clinical-benefit-rate","name":"clinical benefit rate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03359018","title":"Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Peking University People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}